Clinical trial / 2000
Large doses of MSG without food elicited more symptoms than placebo in self-reported MSG-sensitive individuals, but responses were not consistent on retesting.
In a multiphase trial, 130 individuals reporting MSG sensitivity were challenged with MSG and placebo. In protocol A (5 g MSG vs placebo), 38.5% responded to MSG only, 13.1% to placebo only (P < .05), and 14.6% to both. Higher MSG doses in protocol B were linked to increased response rates, but only 19 of 37 subjects who reacted to MSG alone in protocol A did so again in protocol B. In protocol C, only 2 of 19 subjects responded in both challenges to MSG but not placebo, and their symptoms were not reproducible across protocols. When these 2 subjects were tested with food in protocol D, both responded to only one of three MSG challenges. The authors concluded that while large doses without food may elicit more symptoms than placebo, effects were neither persistent nor serious and were inconsistent on retesting.
- Study type
- Multicenter, double-blind, placebo-controlled, crossover multiple-challenge trial
- Who was studied
- 130 self-selected reportedly MSG-reactive volunteers
- What was measured
- Reported symptoms within 2 hours (positive response defined as 2 or more symptoms from a list of 10)
THE PAPER
Multicenter, double-blind, placebo-controlled, multiple-challenge evaluation of reported reactions to monosodium glutamate.
Geha RS, Beiser A, Ren C, Patterson R, Greenberger PA, Grammer LC, Ditto AM, Harris KE, Shaughnessy MA, Yarnold PR, Corren J, Saxon A. J Allergy Clin Immunol, 2000.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.